KAREN ALTOBELLI: Open Payments
NPI 1699714667 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 30 payments from 11 companies in 2025. Trend: 2023 $378 · 2024 $455 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Amgen Inc. | 1 | $127 |
| Phathom Pharmaceuticals, Inc. | 5 | $102 |
| Novo Nordisk Inc | 6 | $100 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| PFIZER INC. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $26 |
| Optinose US, Inc. | 1 | $18 |
Products named: DUPIXENT, BREZTRI, REPATHA, VOQUEZNA, NUCALA, XHANCE, NURTEC ODT, Wegovy.
Industry payments across PA — which companies pay providers there.
